ST
ONCE

Spot Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Spot Trading’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,785
Closed -$141K – 4012
2016
Q1 		$141K Buy
4,785
+4,685
+4,685% +$148K ﹤0.01% 2404
2015
Q4 		$5K Buy
+100
New +$5.24K ﹤0.01% 3415

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Spot Trading's ONCE Position: Q2 2016 in Review

Spot Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2016, closing a stake of 4,785 shares — an estimated $141K sold.

Spot Trading first reported a position in ONCE in Q4 2015 and held it in 2 quarters. The position peaked at $141K in Q1 2016. 115 funds tracked by Wall St. Rank hold ONCE as of Q2 2016.

  • Spot Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 4,785 Spark Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $141K.
  • Spot Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Spot Trading's Spark Therapeutics, Inc. Common Stock position peaked at $141K in Q1 2016.
  • 115 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.